Report Detail

Pharma & Healthcare Global Veterinary Active Pharmaceutical Ingredients (API) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4516443
  • |
  • 27 February, 2023
  • |
  • Global
  • |
  • 108 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Veterinary Active Pharmaceutical Ingredients (API) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
This report is a detailed and comprehensive analysis for global Veterinary Active Pharmaceutical Ingredients (API) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Veterinary Active Pharmaceutical Ingredients (API) market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Veterinary Active Pharmaceutical Ingredients (API)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Veterinary Active Pharmaceutical Ingredients (API) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alivira Animal Health Ltd, Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Procyon Life Sciences, SUANFARMAOfichem Group and NGL Fine-Chem Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Veterinary Active Pharmaceutical Ingredients (API) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemical Based API
Biological API
Highly Potent APl(HPAPI)
Market segment by Application
CDMO
CMO
Major players covered
Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Veterinary Active Pharmaceutical Ingredients (API) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Veterinary Active Pharmaceutical Ingredients (API), with price, sales, revenue and global market share of Veterinary Active Pharmaceutical Ingredients (API) from 2018 to 2023.
Chapter 3, the Veterinary Active Pharmaceutical Ingredients (API) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Veterinary Active Pharmaceutical Ingredients (API) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Veterinary Active Pharmaceutical Ingredients (API) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Veterinary Active Pharmaceutical Ingredients (API).
Chapter 14 and 15, to describe Veterinary Active Pharmaceutical Ingredients (API) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients (API)
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Chemical Based API
    • 1.3.3 Biological API
    • 1.3.4 Highly Potent APl(HPAPI)
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 CDMO
    • 1.4.3 CMO
  • 1.5 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size & Forecast
    • 1.5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity (2018-2029)
    • 1.5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Alivira Animal Health Ltd
    • 2.1.1 Alivira Animal Health Ltd Details
    • 2.1.2 Alivira Animal Health Ltd Major Business
    • 2.1.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.1.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Alivira Animal Health Ltd Recent Developments/Updates
  • 2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
    • 2.2.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Details
    • 2.2.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Major Business
    • 2.2.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.2.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments/Updates
  • 2.3 Procyon Life Sciences
    • 2.3.1 Procyon Life Sciences Details
    • 2.3.2 Procyon Life Sciences Major Business
    • 2.3.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.3.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Procyon Life Sciences Recent Developments/Updates
  • 2.4 SUANFARMAOfichem Group
    • 2.4.1 SUANFARMAOfichem Group Details
    • 2.4.2 SUANFARMAOfichem Group Major Business
    • 2.4.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.4.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 SUANFARMAOfichem Group Recent Developments/Updates
  • 2.5 NGL Fine-Chem Ltd
    • 2.5.1 NGL Fine-Chem Ltd Details
    • 2.5.2 NGL Fine-Chem Ltd Major Business
    • 2.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 NGL Fine-Chem Ltd Recent Developments/Updates
  • 2.6 Huvepharma
    • 2.6.1 Huvepharma Details
    • 2.6.2 Huvepharma Major Business
    • 2.6.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.6.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Huvepharma Recent Developments/Updates
  • 2.7 Jiangsu Lingyun Pharmaceutical Co. Ltd
    • 2.7.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Details
    • 2.7.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Major Business
    • 2.7.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.7.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments/Updates
  • 2.8 Excel Veterinary HealthcareVetpharma(Insud Pharma)
    • 2.8.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Details
    • 2.8.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Major Business
    • 2.8.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.8.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments/Updates
  • 2.9 Menadiona
    • 2.9.1 Menadiona Details
    • 2.9.2 Menadiona Major Business
    • 2.9.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.9.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Menadiona Recent Developments/Updates
  • 2.10 lndukern Group
    • 2.10.1 lndukern Group Details
    • 2.10.2 lndukern Group Major Business
    • 2.10.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.10.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 lndukern Group Recent Developments/Updates
  • 2.11 LasaSupergenerics Ltd.
    • 2.11.1 LasaSupergenerics Ltd. Details
    • 2.11.2 LasaSupergenerics Ltd. Major Business
    • 2.11.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product and Services
    • 2.11.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 LasaSupergenerics Ltd. Recent Developments/Updates

3 Competitive Environment: Veterinary Active Pharmaceutical Ingredients (API) by Manufacturer

  • 3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2018-2023)
  • 3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Veterinary Active Pharmaceutical Ingredients (API) by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Veterinary Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2022
  • 3.5 Veterinary Active Pharmaceutical Ingredients (API) Market: Overall Company Footprint Analysis
    • 3.5.1 Veterinary Active Pharmaceutical Ingredients (API) Market: Region Footprint
    • 3.5.2 Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Type Footprint
    • 3.5.3 Veterinary Active Pharmaceutical Ingredients (API) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region
    • 4.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2029)
    • 4.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Region (2018-2029)
  • 4.2 North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
  • 4.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
  • 4.5 South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
  • 5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Type (2018-2029)
  • 5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
  • 6.2 Global Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Application (2018-2029)
  • 6.3 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
  • 7.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
  • 7.3 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
    • 7.3.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
  • 8.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
  • 8.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
    • 8.3.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region
    • 9.3.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
  • 10.2 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
  • 10.3 South America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
    • 10.3.1 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
    • 11.3.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Veterinary Active Pharmaceutical Ingredients (API) Market Drivers
  • 12.2 Veterinary Active Pharmaceutical Ingredients (API) Market Restraints
  • 12.3 Veterinary Active Pharmaceutical Ingredients (API) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Veterinary Active Pharmaceutical Ingredients (API) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Veterinary Active Pharmaceutical Ingredients (API)
  • 13.3 Veterinary Active Pharmaceutical Ingredients (API) Production Process
  • 13.4 Veterinary Active Pharmaceutical Ingredients (API) Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Veterinary Active Pharmaceutical Ingredients (API) Typical Distributors
  • 14.3 Veterinary Active Pharmaceutical Ingredients (API) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Veterinary Active Pharmaceutical Ingredients (API). Industry analysis & Market Report on Veterinary Active Pharmaceutical Ingredients (API) is a syndicated market report, published as Global Veterinary Active Pharmaceutical Ingredients (API) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Veterinary Active Pharmaceutical Ingredients (API) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,766.60
    4,149.90
    5,533.20
    3,219.00
    4,828.50
    6,438.00
    544,341.60
    816,512.40
    1,088,683.20
    290,684.40
    436,026.60
    581,368.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report